Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.
Feature|Articles|March 17, 2025
- March 2025
- Volume 41
- Issue 2
Incorporating mental health care into primary visits
Author(s)Joshua Fitch, Senior Editor
Pediatricians face rising demands in specialty care and mental health, with programs such as REACH helping them manage these challenges.
Advertisement
Advertisement
General pediatric providers and pediatric specialists across multiple areas of medicine have told Contemporary Pediatrics that general providers are taking on more and more responsibilities. Longer wait times for pediatric specialty care, exacerbated by the COVID-19 pandemic, are still lingering and contributing to these added responsibilities.1
Related to this article
Learn how to distinguish true ADHD from anxiety, trauma, sleep issues, or substance use by tracing symptoms back to childhood across settings and impairment.
NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.
Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
Children with FASD given choline before age 6 had 9.1% higher nonverbal IQ and 11.3% better working memory vs placebo 5 years after treatment.
Emily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.
CDC data show pediatric CP-CRE incidence rose 92% from 2019 to 2024, driven by NDM-CRE, mostly in children with complex medical needs.
Advertisement
Advertisement